欧盟EMA药品数据库(European Medicines Agency Authorisation of Medicines DataBase)
商品名称BTVPUR Alsap 8
适用类别Veterinary
治疗领域
通用名/非专利名称adjuvanted bluetongue virus vaccine
活性成分bluetongue virus serotype 8 antigen
产品号EMEA/V/C/000146
患者安全信息No
许可状态Withdrawn
ATC编码QI02AA08
是否额外监管No
是否仿制药或hybrid药物No
是否生物类似药No
是否附条件批准No
是否特殊情形No
是否加速审评No
是否罕用药No
上市许可日期2009/03/17
上市许可开发者/申请人/持有人Merial
人用药物治疗学分组
兽用药物治疗学分组Immunologicals for Ovidae;Immunologicals for Bovidae
欧盟委员会决定日期2014/03/13
修订号5
治疗适应症Active immunisation of sheep and cattle to prevent viraemia* and to reduce clinical signs caused by bluetongue virus serotype 8.*(below the level of detection by the validated RT-PCR method at 3.14log10 RNA copies/ml, indicating no infectious virus transmission). Onset of immunity has been demonstrated 3 weeks after the primary vaccination course. The duration of immunity for cattle and sheep is 1 year after the primary vaccination course. The duration of immunity is not yet fully established in cattle or sheep, although interim results of ongoing studies demonstrate that the duration is at least 6 months after the primary vaccination course in sheep.
适用物种Sheep;Cattle
兽用药物ATC编码QI02AA08
首次发布日期2014/03/13
最后更新日期2018/05/16
产品说明书https://www.ema.europa.eu/en/documents/product-information/btvpur-alsap-8-epar-product-information_en.pdf
公共评估报告https://www.ema.europa.eu/en/medicines/veterinary/EPAR/btvpur-alsap-8
©2006-2025 DrugFuture->European Medicines Agency Authorisation of Medicines DataBase